⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Elevated cost per beneficiaryHigh antipsychotic prescribing (65+)
Risk indicators are statistical patterns, not allegations. Learn more
4,717
Total Claims
$3.8M
Drug Cost
727
Beneficiaries
$5,174
Cost/Patient
Risk Score Breakdown 14/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
Cost per patient outlier+3
Score components are additive. Read full methodology
Peer Comparison vs. 13,194 Neurology providers
+28%
Cost per patient vs peers
$5,174 vs $4,034 avg
Brand vs Generic
100% generic
Brand: 0 claims · $0
Generic: 3,941 claims · $121K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Immun Glob G(Igg)/Pro/Iga 0-50 | 47 | $1.1M |
| Eculizumab | 15 | $786K |
| Deutetrabenazine | 28 | $174K |
| Immune Globul G/Gly/Iga Avg 46 | 11 | $140K |
| Amantadine Hcl | 31 | $117K |
| Carbidopa/Levodopa | 131 | $91K |
| Onabotulinumtoxina | 69 | $89K |
| Erenumab-Aooe | 85 | $86K |
| Pimavanserin Tartrate | 13 | $73K |
| Rotigotine | 47 | $66K |
| Brivaracetam | 29 | $52K |
| Rimegepant Sulfate | 22 | $33K |
| Brexpiprazole | 15 | $24K |
| Galcanezumab-Gnlm | 22 | $22K |
| Ubrogepant | 17 | $18K |
Prescribing Profile
63
Unique Drugs
14.0
Anomaly Score
Patient Profile
75
Avg Age
53%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About